Detalles de la búsqueda
1.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 573-586, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203067
2.
Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysis.
Haematologica
; 104(5): 1026-1035, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606791
3.
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 587-588, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319872
4.
Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands.
Anticancer Drugs
; 29(8): 791-801, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846248
5.
Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands.
Anticancer Drugs
; 29(6): 579-588, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29634490
6.
Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands.
Anticancer Drugs
; 29(6): 572-578, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29659371
7.
The increasing importance of a continence nurse specialist to improve outcomes and save costs of urinary incontinence care: an analysis of future policy scenarios.
BMC Fam Pract
; 19(1): 31, 2018 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29454331
8.
Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences.
Value Health
; 20(4): 627-636, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28408005
9.
Policymaker, please consider your needs carefully: does outcomes research in relapsed or refractory multiple myeloma reduce policymaker uncertainty regarding value for money of bortezomib?
Value Health
; 17(2): 245-53, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24636383
10.
Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma.
JAMA Netw Open
; 4(3): e213497, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33779744
11.
Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003-2018): A nationwide population-based study.
Eur J Cancer
; 154: 111-119, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256280
12.
Real-world healthcare costs of localized and regionally advanced cutaneous melanoma in the Netherlands.
Melanoma Res
; 31(3): 249-257, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33871398
13.
The unit costs of inpatient hospital days, outpatient visits, and daycare treatments in the fields of oncology and hematology.
Value Health
; 13(6): 712-9, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20561330
14.
Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.
Cancers (Basel)
; 12(5)2020 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32392717
15.
Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs.
Cancers (Basel)
; 12(4)2020 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32325748
16.
A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma.
Eur J Cancer
; 123: 58-71, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31670077
17.
Stage-specific disease recurrence and survival in localized and regionally advanced cutaneous melanoma.
Eur J Surg Oncol
; 45(5): 825-831, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765270
18.
Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry.
Cancers (Basel)
; 11(7)2019 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31323802
19.
Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes.
Melanoma Res
; 28(4): 326-332, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29750749
20.
Systematic Literature Review and Network Meta-Analysis of Treatment Outcomes in Relapsed and/or Refractory Multiple Myeloma.
J Clin Oncol
; 35(12): 1312-1319, 2017 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28240968